The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia.

The FDA has approved Rapiblyk, a new drug to treat irregular heartbeats in critically ill hospitalized patients with severe ...

VIENNA--AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug ...

Pulsed field ablation (PFA) has gained attention in cardiac electrophysiology, but data on its application to paroxysmal supraventricular tachycardia are limited. This study aimed to assess the ...

U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting ...

Supraventricular arrhythmias are the most widespread group of arrhythmias and affect all age groups. Atrial fibrillation is the most common arrhythmic disorder and is even more prevalent among the ...

Background: Paroxysmal supraventricular tachycardia (PSVT) is one of the most common arrhythmias among pregnant women, in part due to the maternal physiological changes that occur during pregnancy.

The following is a summary of “Role of Troponin Testing in Patients with Supraventricular Tachycardia, Systematic Review and ...

[15] Supraventricular arrhythmias may occur in the pre- and post-MI setting. Causes of SVT include: irritation of atrial myocardium as a result of pericarditis; elevated atrial pressures resulting ...

Supraventricular tachyarrhythmia (SVT) is the most common form of fetal tachyarrhythmias. The presentation can vary from ill-defined, non-sustained episodes of tachyarrhythmia to frank non-immune ...

The S1 heart sound is two of your heart valves closing. It's the first sound doctors can hear with a stethoscope. Learn what ...